secwatch.observer — SEC 8-K summary
======================================

Issuer:     SKYX Platforms Corp. (SKYX)
CIK:        0001598981
Form:       8-K
Filed at:   2026-10-01T21:15:39+00:00
Accession:  0001493152-26-045379
Event type: leadership
Sentiment:  negative
Materiality: 0.35
Item codes: 3.01
LLM model:  deepseek-v4.1-flash:cloud@v2

SKYX director Efrat Greenstein Brayer dies; Nasdaq flags board/audit committee noncompliance with cure to 2027
--------------------------------------------------------------------------------

- Independent director Efrat L. Greenstein Brayer, chair of the nominating and corporate governance committee and member of the audit and compensation committees, died September 26, 2026.
- SKYX notified Nasdaq on September 28, 2026 that it no longer meets Listing Rule 5605(b)(1) (majority independent board) and Rule 5605(c)(2)(A) (three-member audit committee).
- Nasdaq's September 30, 2026 letter grants a cure period expiring at the earlier of the next annual meeting or September 26, 2027; March 25, 2027 if the annual meeting is held before then.
- Company says it intends to regain compliance before the cure period lapses; no immediate effect on its Nasdaq listing, and it warns there is no assurance it will succeed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598981/000149315226045379/0001493152-26-045379-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598981/000149315226045379/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-045379

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer